Open AccessEffectiveness of Dupilumab for an Elderly Patient with Prurigo Nodularis Who Was Refractory and Contradicted to Traditional Therapy
Author(s) -
Taoming Liu,
Juan Bai,
Su Wang,
Shilong Ying,
Sheng Li,
Jianjun Qiao,
Hong Fang
Publication year - 2021
Publication title -
journal of asthma and allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.162
H-Index - 30
ISSN - 1178-6965
DOI - 10.2147/jaa.s300975
Subject(s) - prurigo nodularis , dupilumab , medicine , refractory (planetary science) , dermatology , eczematous dermatitis , prurigo , rescue therapy , atopic dermatitis , methotrexate , dermatologic agents , surgery , physics , astrobiology , microbiology and biotechnology , biology , antibiotics
Prurigo nodularis (PN) is an intense pruritic skin condition. Treatment of PN is challenging. We described an elderly patient with PN who had contradictions of cyclosporine or methotrexate and achieved significant improvement after treatment with dupilumab. We also reviewed published cases of elderly patients with PN who were refractory to traditional therapy.